Zydus receives final approval for Fesoterodine Fumarate Extended Release Tablets
From USFDA
Zydus Cadila has received the final approval from the USFDA to market Fesoterodine Fumarate Extended Release Tablets, 4 mg and 8 mg. It will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content